Baidu
map

Diabetes:二型糖尿病,原来是非酯化游离脂肪酸惹的祸?

2019-12-30 王芳 生物探索

一项刊发于美国《Diabetes》杂志的新研究提出了一种专门调节胰岛中非葡萄糖刺激的胰岛素分泌(NGSIS)的机制,该机制由非酯化的游离脂肪酸(禁食期间β细胞利用的主要燃料)激活。

糖尿病是一组以高血糖为特征的代谢性疾病,已经成为危害人类健康的“第三大杀手”。按胰岛素分泌的情况,糖尿病可分为1型和2型,2型糖尿病与胰岛素抵抗和胰岛β细胞功能缺陷有关,且多见于成人。据统计,中国2型糖尿病的患病率达11.6%,而糖尿病前期人群更是高达 50.1%。也就是说2个成人里就有1个是“糖尿病”的“后备军”。

在糖尿病研究中,一个核心问题是,为什么β细胞最初会分泌过多的胰岛素。通俗的说法是,此时人体可能感知不到胰岛素的存在,因此β细胞会分泌更多胰岛素来引起人体的“注意”。但让人困惑的是,即使是实验室培养皿中分离出的β细胞也会过度分泌胰岛素。

一项刊发于美国《Diabetes》杂志的新研究提出了一种专门调节胰岛中非葡萄糖刺激的胰岛素分泌(NGSIS)的机制,该机制由非酯化的游离脂肪酸(禁食期间β细胞利用的主要燃料)激活。

在实验过程中,科学家以普通小鼠和糖尿病前期小鼠为对象,对机体在没有葡萄糖的情况下分泌胰岛素的机制进行了研究。结果发现,在糖尿病前期小鼠的β细胞中,线粒体通透性转换孔调节因子环亲素D(CypD)通过增加线粒体质子泄漏,能够在葡萄糖没有升高的情况下促进胰岛素的分泌。与瘦小鼠相比,糖尿病前肥胖小鼠的胰岛显示出明显更高的CypD依赖性质子泄漏和NGSIS。其机制依赖于脂肪酸,而脂肪酸通常不能刺激健康动物的胰岛素分泌。



另外,缺乏CypD基因的肥胖小鼠不会分泌过量的胰岛素。实验过程中,研究人员观察到,NGSIS也发生在分离的人类胰腺细胞中:当脂肪酸水平达到肥胖群体的典型水平时,细胞能够在没有葡萄糖升高的情况下分泌胰岛素。

总之,这项研究揭示了选择性驱动胰岛NGSIS的非酯化游离脂肪酸刺激途径,同时也为我们提供了预防胰岛素抵抗和治疗糖尿病的新方法,包括通过阻止β细胞质子泄漏来阻止其进展。

原始出处:Evan P. Taddeo, Nour Alsabeeh, Siyouneh Baghdasarian, et al. Mitochondrial Proton Leak Regulated by Cyclophilin D elevates Insulin Secretion in Islets at Non-Stimulatory Glucose Levels. Diabetes 2019 Nov

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1951736, encodeId=8c051951e3626, content=<a href='/topic/show?id=44a266383f5' target=_blank style='color:#2F92EE;'>#游离脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66383, encryptionId=44a266383f5, topicName=游离脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Jul 14 15:03:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902365, encodeId=ceb7190236517, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 12 01:03:00 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735671, encodeId=b4231e3567147, content=<a href='/topic/show?id=170723886f3' target=_blank style='color:#2F92EE;'>#二型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23886, encryptionId=170723886f3, topicName=二型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3633942784, createdName=周虎, createdTime=Fri Jan 31 14:03:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761287, encodeId=62d31e6128737, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 11 19:03:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639321, encodeId=fb931639321d6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 14 12:03:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042907, encodeId=6efc104290e37, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 30 15:03:00 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1951736, encodeId=8c051951e3626, content=<a href='/topic/show?id=44a266383f5' target=_blank style='color:#2F92EE;'>#游离脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66383, encryptionId=44a266383f5, topicName=游离脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Jul 14 15:03:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902365, encodeId=ceb7190236517, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 12 01:03:00 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735671, encodeId=b4231e3567147, content=<a href='/topic/show?id=170723886f3' target=_blank style='color:#2F92EE;'>#二型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23886, encryptionId=170723886f3, topicName=二型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3633942784, createdName=周虎, createdTime=Fri Jan 31 14:03:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761287, encodeId=62d31e6128737, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 11 19:03:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639321, encodeId=fb931639321d6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 14 12:03:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042907, encodeId=6efc104290e37, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 30 15:03:00 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1951736, encodeId=8c051951e3626, content=<a href='/topic/show?id=44a266383f5' target=_blank style='color:#2F92EE;'>#游离脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66383, encryptionId=44a266383f5, topicName=游离脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Jul 14 15:03:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902365, encodeId=ceb7190236517, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 12 01:03:00 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735671, encodeId=b4231e3567147, content=<a href='/topic/show?id=170723886f3' target=_blank style='color:#2F92EE;'>#二型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23886, encryptionId=170723886f3, topicName=二型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3633942784, createdName=周虎, createdTime=Fri Jan 31 14:03:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761287, encodeId=62d31e6128737, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 11 19:03:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639321, encodeId=fb931639321d6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 14 12:03:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042907, encodeId=6efc104290e37, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 30 15:03:00 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1951736, encodeId=8c051951e3626, content=<a href='/topic/show?id=44a266383f5' target=_blank style='color:#2F92EE;'>#游离脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66383, encryptionId=44a266383f5, topicName=游离脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Jul 14 15:03:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902365, encodeId=ceb7190236517, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 12 01:03:00 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735671, encodeId=b4231e3567147, content=<a href='/topic/show?id=170723886f3' target=_blank style='color:#2F92EE;'>#二型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23886, encryptionId=170723886f3, topicName=二型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3633942784, createdName=周虎, createdTime=Fri Jan 31 14:03:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761287, encodeId=62d31e6128737, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 11 19:03:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639321, encodeId=fb931639321d6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 14 12:03:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042907, encodeId=6efc104290e37, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 30 15:03:00 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1951736, encodeId=8c051951e3626, content=<a href='/topic/show?id=44a266383f5' target=_blank style='color:#2F92EE;'>#游离脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66383, encryptionId=44a266383f5, topicName=游离脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Jul 14 15:03:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902365, encodeId=ceb7190236517, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 12 01:03:00 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735671, encodeId=b4231e3567147, content=<a href='/topic/show?id=170723886f3' target=_blank style='color:#2F92EE;'>#二型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23886, encryptionId=170723886f3, topicName=二型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3633942784, createdName=周虎, createdTime=Fri Jan 31 14:03:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761287, encodeId=62d31e6128737, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 11 19:03:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639321, encodeId=fb931639321d6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 14 12:03:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042907, encodeId=6efc104290e37, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 30 15:03:00 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1951736, encodeId=8c051951e3626, content=<a href='/topic/show?id=44a266383f5' target=_blank style='color:#2F92EE;'>#游离脂肪酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66383, encryptionId=44a266383f5, topicName=游离脂肪酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Tue Jul 14 15:03:00 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902365, encodeId=ceb7190236517, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon Oct 12 01:03:00 CST 2020, time=2020-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735671, encodeId=b4231e3567147, content=<a href='/topic/show?id=170723886f3' target=_blank style='color:#2F92EE;'>#二型糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23886, encryptionId=170723886f3, topicName=二型糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b3633942784, createdName=周虎, createdTime=Fri Jan 31 14:03:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1761287, encodeId=62d31e6128737, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sun Oct 11 19:03:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639321, encodeId=fb931639321d6, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Dec 14 12:03:00 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042907, encodeId=6efc104290e37, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Mon Dec 30 15:03:00 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
    2019-12-30 misszhang

    谢谢MedSci提供最新的资讯

    0

相关资讯

Diabetologia:寻找糖尿病的因果途径:一项使用蛋白质组学和基因分型数据的横断面研究

2型糖尿病的发病机制尚不完全清楚。本研究调查了预先选择循环水平的蛋白质是否与结果“糖尿病”相关,以及这些关联是否有因果关系。

Diabetologia:胰岛素原肽可促进自身免疫性糖尿病?

最近对儿童的自然史研究表明,特定的HLA基因型与免疫反应的第一个抗原靶点之间存在联系。然而目前,关于特异性HLA分子对1型糖尿病等自身免疫性疾病病理影响的分子基础尚不清楚。本研究以一种常见的糖尿病相关HLA单倍型为背景,通过探讨胰岛抗原的致糖尿病性来研究这种体内联系。

Diabetologia:长链非编码RNA HOTAIR在糖尿病肾病中的表达失调及功能重复

长链非编码RNA (Long non-coding RNAs, lncRNAs)因其在慢性疾病(包括糖尿病肾病(DKD))发病机制中的作用而受到越来越多的关注。然而,关于成年体内lncRNA的功能仍不清楚。为了更好地理解lncRNA在DKD中的调控和功能,我们探索了模块化支架lncRNA HOTAIR (HOX反义基因间RNA) 将染色质修饰复合物拉近其基因组靶位的作用。

Diabetologia:短期力量和平衡训练并不能改善生活质量,但可以改善糖尿病周围神经病变患者的功能状态?

本研究的目的是测试结构性力量和平衡训练干预对改善糖尿病周围神经病变(DPN)患者健康相关生活质量(HRQoL)和功能状态的有效性。

Lancet Diabetes Endo:胰岛素抵抗、β细胞功能障碍、肥胖对中国糖尿病风险的影响

研究发现,在中国成年人中,胰岛素抵抗比β-细胞功能障碍更容易导致糖尿病,在肥胖人群中更为明显

JAMA :美国西班牙裔和亚裔人群糖尿病发病率研究

在2011-2016年美国成年人的全国代表性调查中,美国西班牙裔和亚裔人群糖尿病和未确诊糖尿病的患病率存在较大的差异

Baidu
map
Baidu
map
Baidu
map